日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

TRIO-15 是一项多中心、开放标签的 II 期研究,旨在评估加尼妥单抗治疗复发性铂敏感卵巢癌患者的疗效和安全性。

Davidson, T M; Lebreton, C L; Hendricksen, A E Wahner; Atkinson, H J; Larson, M C; Oberg, A L; Provencher, D M; Glaspy, J A; Karlan, B Y; Slamon, D J; Konecny, G E; Ray-Coquard, I L

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

OV21/PETROC:一项由妇科肿瘤协作组开展的随机II期研究,比较新辅助化疗和最佳肿瘤细胞减灭术后,上皮性卵巢癌患者接受腹腔内化疗与静脉内化疗的疗效。

Provencher, D M; Gallagher, C J; Parulekar, W R; Ledermann, J A; Armstrong, D K; Brundage, M; Gourley, C; Romero, I; Gonzalez-Martin, A; Feeney, M; Bessette, P; Hall, M; Weberpals, J I; Hall, G; Lau, S K; Gauthier, P; Fung-Kee-Fung, M; Eisenhauer, E A; Winch, C; Tu, D; MacKay, H J

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours

妇科肿瘤协作组(GCIG)第五届卵巢癌共识会议:罕见卵巢肿瘤的临床试验设计

Leary, A F; Quinn, M; Fujiwara, K; Coleman, R L; Kohn, E; Sugiyama, T; Glasspool, R; Ray-Coquard, I; Colombo, N; Bacon, M; Zeimet, A; Westermann, A; Gomez-Garcia, E; Provencher, D; Welch, S; Small, W; Millan, D; Okamoto, A; Stuart, G; Ochiai, K

Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec

筛查史和与医生的接触情况作为魁北克省蒙特利尔市宫颈癌风险的决定因素

Spence, A R; Alobaid, A; Drouin, P; Goggin, P; Gilbert, L; Provencher, D; Tousignant, P; Hanley, J A; Franco, E L

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

在卵巢上皮癌细胞系中过度表达 CCL2 趋化因子会导致体内致瘤性的潜伏

Wojnarowicz P, Gambaro K, de Ladurantaye M, Quinn M C J, Provencher D, Mes-Masson A-M, Tonin P N

Multimodality breast cancer screening in women with a familial or genetic predisposition

对有家族或遗传易感性的女性进行多模式乳腺癌筛查

Trop, I; Lalonde, L; Mayrand, M H; David, J; Larouche, N; Provencher, D

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

法国加拿大乳腺癌和卵巢癌家族中的BRCA1和BRCA2基因突变

Tonin, P N; Mes-Masson, A M; Futreal, P A; Morgan, K; Mahon, M; Foulkes, W D; Cole, D E; Provencher, D; Ghadirian, P; Narod, S A

Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay

采用非放射性同位素PCR法检测宫颈冲洗液标本中人乳头瘤病毒DNA

Coutlée, F; Provencher, D; Voyer, H